Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
36,412,708
-
Share change
-
+3,106,376
-
Total reported value
-
$564,621,911
-
Put/Call ratio
-
20%
-
Price per share
-
$15.52
-
Number of holders
-
74
-
Value change
-
+$45,537,584
-
Number of buys
-
47
-
Number of sells
-
30
Institutional Holders of DICE THERAPEUTICS INC - COM (DICE) as of Q2 2022
As of 30 Jun 2022,
DICE THERAPEUTICS INC - COM (DICE) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,412,708 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Northpond Ventures, LLC, Sands Capital Ventures, LLC, PRICE T ROWE ASSOCIATES INC /MD/, DRIEHAUS CAPITAL MANAGEMENT LLC, FMR LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, EVENTIDE ASSET MANAGEMENT, LLC, and VANGUARD GROUP INC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.